Effect of levocarnitine administration in patients with chronic liver disease.
Ohashi K, Ishikawa T, Hoshii A, Hokari T, Suzuki M, Noguchi H, Hirosawa H, Koyama F, Kobayashi M, Hirosawa S, Sugiyama K, Mitobe Y, Yoshida T.
Ohashi K, et al. Among authors: hokari t.
Exp Ther Med. 2020 Nov;20(5):94. doi: 10.3892/etm.2020.9222. Epub 2020 Sep 16.
Exp Ther Med. 2020.
PMID: 32973943
Free PMC article.